* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Note: Incomplete sections will be updated when information
Minimal genome wikipedia , lookup
Pathogenomics wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Polymorphism (biology) wikipedia , lookup
Y chromosome wikipedia , lookup
Genomic imprinting wikipedia , lookup
Gene expression profiling wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Human genome wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Fetal origins hypothesis wikipedia , lookup
Gene therapy wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
X-inactivation wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Oncogenomics wikipedia , lookup
Gene expression programming wikipedia , lookup
Genome evolution wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Genetic engineering wikipedia , lookup
Heritability of IQ wikipedia , lookup
Population genetics wikipedia , lookup
Quantitative trait locus wikipedia , lookup
History of genetic engineering wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Genetic testing wikipedia , lookup
Human genetic variation wikipedia , lookup
Behavioural genetics wikipedia , lookup
Microevolution wikipedia , lookup
Designer baby wikipedia , lookup
Medical genetics wikipedia , lookup
Note: Incomplete sections will be updated when information becomes available MASSEY UNIVERSITY COLLEGE OF SCIENCES Paper Outline 2011 Paper Number and Title: 203203 Human Genetics Credits value: 15 Campus: Manawatu Campus: Albany Campus: Manawatu Semester: 1101 Semester: 1101 Semester: 1112 Mode: Mode: Mode: Internal Block Distance Calendar Prescription: Aspects of genetics that are important in human biology. Topics include chromosome abnormalities, genes and genetic disease, immunogenetics, cancer, ageing, complex traits, family studies and populations. Pre-requisites: Co-requisites: Restrictions: 162.101 162.253 E-Learning Category: Required - essential Paper Coordinator Albany Dr Gabrielle Schmidt-Adam Office: Building 14, Room 10 Email: [email protected] Phone: x. 9860 Paper Coordinator Manawatu: And Distance Mode Dr Neville Honey Office: ScC2.06 Email: [email protected] Phone: extn. 2573 Learning Outcomes: On successful completion a student will be able to: 1. understand genetic principles 2. understand the role of genetics in human biology 3. communicate his/her understanding of human genetics Alignment of Assessment to Learning outcomes Assessment – Internal Mode Semester test 4 x Online tests Poster Final exam Assessment – Distance Mode 4 x Assignments Final exam Learning Outcomes Assessed 1. 2. 3. × Contribution to Paper Mark 15% 10% 15% 60% 40% 60% Note: Incomplete sections will be updated when information becomes available Assessments and Deadlines Internal Mode Assessment Due Date / Deadline Semester test 2 May 4 × Online tests 24 March 13 April 19 May 9 June Poster 30 May Final exam See timetable Distance Mode Assessment Due Date / Deadline 4 × Assignments Final exam See timetable Late Penalty Paper completion requirement Late Penalty Paper completion requirement The turnaround time for assignments will be no more than three weeks from the due date. It is important to note that the specified timeframe applies only to those assignments submitted by the due date, and does not necessarily apply to those submitted late. Additional Requirements for Paper Completion Student Time Budget: A 15 credit paper equates to 12.5 hours per week, studying 4 papers full time equals 50 hours per week. Textbook and Other Recommended Reading, Online Resources: Either: Human Genetics: concepts and applications, 8th edition, R Lewis Or: Human Genetics: concepts and applications, 9th edition, R Lewis There is a webCT site Conditions for Aegrotat Pass and Impaired Performance: If you are prevented by illness, injury or serious crisis from attending an examination (or completing an element of assessment by the due date), or if you consider that your performance has been seriously impaired by such circumstances, you may apply for aegrotat or impaired performance consideration. You must apply on the form available from the Examinations Office, the Student Health Service or the Student Counseling Service. To qualify for an aegrotat pass on the final examination, you must have attempted at least 40% of the total formal assessment and your performance must be well above the minimum pass standard, so that the examiners can be confident that you would have passed the paper if you had completed the final examination. You may also apply for aegrotat consideration for other compulsory assessment elements (such as Semester Tests) that occur at a fixed time and place if you are prevented by illness, injury or a serious crisis from attending. Plagiarism: Massey University, College of Sciences, has taken a firm stance on plagiarism and any form of cheating. Plagiarism is the copying or paraphrasing of another person’s work, whether published or unpublished, without clearly acknowledging it. It includes copying the work of other students. Plagiarism will be penalized; it is likely to lead to loss of marks for that item of assessment and may lead to an automatic failing grade for the paper and/or exclusion from reenrollment at the University. Note: Incomplete sections will be updated when information becomes available Grievance Procedures: A student who claims that he/she has sustained academic disadvantage as a result of the actions of a University staff member should use the University Grievance Procedures. Students, whenever practicable, should in the first instance approach the University staff member concerned. If the grievance is unresolved with the staff member concerned, the student should then contact the College of Sciences office on his/her campus for further information on the procedures, or read the procedures in the University Calendar. 203.203 Human Genetics Lecture outline 2011 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. Introduction: genes and the environment. Impact of genetic disease. Teratogens: classes of teratogen, factors in teratogen action. Chromosomes. The karyotype. Variations in autosome number: chromosome 21, autosomes, whole chromosome sets. Variations in sex chromosome number: X and Y chromosome. Variations in chromosome structure: duplication, deletion, inversion Variations in chromosome structure: translocation, isochromosomes, ring chromosomes. Other variants: mosaics, genetic imprints (disorders resulting from mutant allele or uniparental disomy). Sex development: mechanism, XY females, XX males, XY testicular disorders in sex development (DSD), XX ovarian DSD, ovotestes DSD. Genes and genetic disease. Molecular characterisation: mutations, globin gene organisation. Globin disorders (examples of codon substitution, loss of stop codon, frameshift, new stop codon, hybrid protein, reduced protein levels). Trinucleotide repeat expansion mutations (fragile X, Huntington). Genetic characterisation: dominant or recessive mutant alleles. Inheritance: pedigree symbols, patterns of inheritance (autosomal dominant and recessive, X-linked dominant and recessive, Y-linked, mitochondrial). Phenotypic characterisation: expression of a disorder (different genes, age of onset, pleiotropy, mental function) variability in expression (expressivity, affected expression, penetrance). Cancer and Ageing. Cancer: cancer is a somatic genetic disease, Ames test, identifying cancer genes, repair and stability genes (XP, AT). Cancer: oncogenes (origins, CML, Burkitt’s lymphoma), tumour suppressor genes (Retinoblastoma, p53, NF1). Ageing: role of mutations, chromosome clock. Ageing: genes that affect ageing, premature ageing syndromes, natural selection and ageing. Complex traits. Introduction: continuous traits, thresholds. Analysis: recurrence risk, twin studies (% concordance, correlation coefficient) Analysis: twin studies, cont. (heritability), genome wide association studies. Disease: diabetes, obesity, Alzheimer. Behaviour: studying behaviour (alcoholism). Behaviour: neurotransmitters and personality (serotonin and unipolar affective disorders, dopamine and schizophrenia, MAOA). Behaviour: Intelligence (twin studies, genes, environmental factors), Issues. Note: Incomplete sections will be updated when information becomes available 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33. 34. Immunogenetics. Introduction to the immune system. Cellular response (overview, HLA system). Humoral response (overview, antibody diversity). ABO blood group (ABO gene, H gene). Immune system causing disease (Rh incompatibility, allergies, organ transplants, autoimmune disease, immune deficiency disease). Family studies. Genetic counselling: reasons, stages of counselling, counselling in NZ. Genetic testing: reasons for testing. Genetic testing: population screening, the personal genome (pharmacogenetics, personalised cancer therapy). The personal genome, cont (risk of complex disease). DNA profiles. Diagnosis: cytogenetic studies, biochemical assays, DNA tests, genetic linkage (LOD score). Diagnosis: risk (probabilities of inheritance, factors that can affect risk calculation, Bayesian analysis). Managing genetic disorders: options, treatment strategies (tissue, biochemical, gene product). Treatment strategies, cont. (overcoming the effects of a mutant gene, germ line or zygote gene therapy, somatic cell therapy). Populations. Genetic variation (polymorphism, allele frequency, population studies of disease). Human origins: the hominin lineage (Neanderthal). Human origins: modern humans (Out of Africa or Multiregional, when did they arise?). Human dispersal: Europeans, Americas, Polynesians. Natural selection in modern humans: founder effect or population bottleneck (porphyria, Pingelapese blindness). Natural selection in modern humans: disease (cystic fibrosis, malaria and sickle cell anaemia, PKU, HIV), diet(vitamin D, lactose persistence, type 2 diabetes), the future. Eugenics: negative and positive eugenics, issues.